Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters

Language
Document Type
Year range
1.
Temida ; 24(3):303-327, 2021.
Article in English | Web of Science | ID: covidwho-1770944

ABSTRACT

In June 2020 India opted for banning 59 Chinese Apps. Contrary to the apprehension of banning gaming apps including PUBG, the government did not do so when the Chinese apps were banned. But soon PUBG also got banned in India. Several stakeholders had raised their concerns in this regard as PUBG may affect the mental health of children who are the major users of this app. But on the other hand, it had been observed that PUBG had remained the biggest respite for children who were confined to homes due to COVID-19. S.69A of the Information Technology Act 2000 (amended in 2008) had been the main tool by the government to block access to Chinese apps. PUBG developers had however tried to outsmart S.69A of the Information Technology Act, 2000 (amended in 2008), which had been used primarily to block the website and by using Artificial Intelligence for preventing children below 18 from being engaged for a continuous period, being exposed to nudity, etc. This article aims to analyse the tussle between the scope and inherent meaning of S.69A and 79 of the Indian Information technology Act, 2000 (amended in 2008) and the ever-developing due diligence of the game developers with special concern for child safety and mental health of the children, which may make the later a winner or a loser in the legal battleground.

2.
The Journal of the Association of Physicians of India ; 69(7):11-12, 2021.
Article in English | Scopus | ID: covidwho-1431386

ABSTRACT

BACKGROUND: Since its first identification in December 2019, in WUHAN (CHINA), SARS-COV-2, causative agent of Corona virus pandemic, has affected millions of people worldwide, causing thousands of death. There is much speculation about the interplay between ACEI/ARB and Corona virus infection, as for internalization into host cell SARS-COV-2 binds through S spike protein to ACE-2, aided TMPRSS2. METHODS: A record based observational study has been conducted (data obtained from the clinics of fourteen physicians) in two worst affected districts of West Bengal, to find out the association of ACEI/ARB on patients, suffering from Corona virus infection. The study-protocol has already been approved by Clinical Research Ethics Committee of Calcutta School of Tropical Medicine. (IEC Ref. No: CREC-STM/2020-AS-37) Results: Increasing age, male sex and presence of co-morbidities (viz. Diabetes, COPD) are significantly associated with the occurrence of moderate and severe disease. Drugs (viz. ACEI/ARB), though are associated with less severe disease, have not achieved statistical significance, in the present study. CONCLUSION: Drugs, like ACEI/ARB, should be continued in patients suffering from COVID-19 infection, (if they are already on these drugs). © Journal of the Association of Physicians of India 2011.

3.
Journal of Association of Physicians of India ; 69(7):28-33, 2021.
Article in English | Scopus | ID: covidwho-1361002

ABSTRACT

Background: Since its first identification in December 2019, in WUHAN (CHINA), SARS-COV-2, causative agent of Corona virus pandemic, has affected millions of people worldwide, causing thousands of death. There is much speculation about the interplay between ACEI/ARB and Corona virus infection, as for internalization into host cell SARS-COV-2 binds through S spike protein to ACE-2, aided TMPRSS2. Methods: A record based observational study has been conducted (data obtained from the clinics of fourteen physicians) in two worst affected districts of West Bengal, to find out the association of ACEI/ARB on patients, suffering from Corona virus infection. The study-protocol has already been approved by Clinical Research Ethics Committee of Calcutta School of Tropical Medicine. (IEC Ref. No: CREC-STM/2020-AS-37) Results: Increasing age, male sex and presence of co-morbidities (viz. Diabetes, COPD) are significantly associated with the occurrence of moderate and severe disease. Drugs (viz. ACEI/ARB), though are associated with less severe disease, have not achieved statistical significance, in the present study. Conclusion: Drugs, like ACEI/ARB, should be continued in patients suffering from COVID-19 infection, (if they are already on these drugs). © 2021 Journal of Association of Physicians of India. All rights reserved.

SELECTION OF CITATIONS
SEARCH DETAIL